Literature DB >> 26874068

Expression and cellular distribution of transient receptor potential vanilloid 4 in cortical tubers of the tuberous sclerosis complex.

Xin Chen1, Meihua Yang1, Feiji Sun1, Chao Liang1, Yujia Wei1, Lukang Wang1, Jiong Yue1, Bing Chen1, Song Li1, Shiyong Liu2, Hui Yang3.   

Abstract

Cortical tubers in patients with tuberous sclerosis complex (TSC) are highly associated with intractable epilepsy. Recent evidence has shown that transient receptor potential vanilloid 4 (TRPV4) has direct effects on both neurons and glial cells. To understand the role of TRPV4 in pathogenesis of cortical tubers, we investigated the expression patterns of TRPV4 in cortical tubers of TSC compared with normal control cortex (CTX). We found that TRPV4 was clearly up-regulated in cortical tubers at the protein levels. Immunostaining indicated that TRPV4 was specially distributed in abnormal cells, including dysplastic neurons (DNs) and giant cells (GCs). In addition, double immunofluorescent staining revealed that TRPV4 was localized on neurofilament proteins (NF200) positive neurons and glial fibrillary acidic portein (GFAP) positive reactive astrocytes. Moreover, TRPV4 co-localized with both glutamatergic and GABAergic neurons. Furthermore, protein levels of protein kinase C (PKC), but not protein kinase A (PKA), the important upstream factors of the TRPV4, were significantly increased in cortical tubers. Taken together, the overexpression and distribution patterns of TRPV4 may be linked with the intractable epilepsy caused by TSC.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epilepsy; Protein kinase A; Protein kinase C; Transient receptor potential vanilloid 4; Tuberous sclerosis complex

Mesh:

Substances:

Year:  2016        PMID: 26874068     DOI: 10.1016/j.brainres.2016.02.012

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Blockage of TRPV4 Downregulates the Nuclear Factor-Kappa B Signaling Pathway to Inhibit Inflammatory Responses and Neuronal Death in Mice with Pilocarpine-Induced Status Epilepticus.

Authors:  Dong An; Xiuting Qi; Kunpeng Li; Weixing Xu; Yue Wang; Xi Chen; Sha Sha; Chunfeng Wu; Yimei Du; Lei Chen
Journal:  Cell Mol Neurobiol       Date:  2022-07-15       Impact factor: 4.231

2.  Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) Mitigates Seizures.

Authors:  Meng-Liu Zeng; Jing-Jing Cheng; Shuo Kong; Xing-Liang Yang; Xiang-Lei Jia; Xue-Lei Cheng; Ling Chen; Fang-Gang He; Yu-Min Liu; Yuan-Teng Fan; Lanzi Gongga; Tao-Xiang Chen; Wan-Hong Liu; Xiao-Hua He; Bi-Wen Peng
Journal:  Neurotherapeutics       Date:  2022-02-18       Impact factor: 6.088

3.  Activation of TRPV4 Induces Exocytosis and Ferroptosis in Human Melanoma Cells.

Authors:  Mei Li; Jiaojiao Zheng; Tian Wu; Yulin He; Jing Guo; Jiao Xu; Chuanzhou Gao; Shuxian Qu; Qianyi Zhang; Jiayu Zhao; Wei Cheng
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

4.  TRPV4 Regulates Soman-Induced Status Epilepticus and Secondary Brain Injury via NMDA Receptor and NLRP3 Inflammasome.

Authors:  Shuai Wang; Huanhuan He; Jianhai Long; Xin Sui; Jun Yang; Guodong Lin; Qian Wang; Yongan Wang; Yuan Luo
Journal:  Neurosci Bull       Date:  2021-03-24       Impact factor: 5.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.